arrow_back Back to App

Down Syndrome Research Support: New Programs and Funding

The "DeOndra Dixon INCLUDE Project Act of 2024" aims to significantly boost research, training, and investigations related to Down syndrome. Citizens, especially families of individuals with Down syndrome, can expect improved medical care, new therapies, and enhanced quality of life through a better understanding of the condition and its co-occurring disorders. $90 million annually is authorized for this purpose from 2025 to 2029.
Key points
Increased funding for Down syndrome research: $90 million annually for fiscal years 2025-2029.
Development of new medical therapies and interventions, including pharmacological, for individuals with Down syndrome.
Better understanding of co-occurring conditions like Alzheimer's Disease and autoimmunity in individuals with Down syndrome.
Improved quality of life for individuals with Down syndrome and their families through targeted research and support.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7406
Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
Process start date: 2024-02-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

DeOndra Dixon INCLUDE Project Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7406.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-02-16.

What are the main provisions?

Key points include:

  • Increased funding for Down syndrome research: $90 million annually for fiscal years 2025-2029.
  • Development of new medical therapies and interventions, including pharmacological, for individuals with Down syndrome.
  • Better understanding of co-occurring conditions like Alzheimer's Disease and autoimmunity in individuals with Down syndrome.
  • Improved quality of life for individuals with Down syndrome and their families through targeted research and support.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McMorris Rodgers, Cathy [R-WA-5].

What is the latest detailed status?

The latest detailed status is: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5304-5305)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Family